Therefore, we employed KCa3.1-specific blocker senicapoc (Fig. 2a–d, f) and KCa3.1−/− mutant mice (Fig. 2e, g) to explore the function of KCa3.1 in the MPTP-induced PD mouse model. This evidence concerns the gene KCNN4 and Parkinson disease.